SCI-Expanded
JCR Q1
Özgün Makale
Scopus
Are decreased cocaine- and amphetamine regulated transcript and Agouti- related peptide levels associated eating behavior in medication-free children with attention deficit and hyperactivity disorder?
Progress in Neuro-Psychopharmacology & Biological Psychiatry
2024
Cilt 129
Scopus Eşleşmesi Bulundu
3
Atıf
129
Cilt
Özet
This study aimed to investigate plasma levels of cocaine- and amphetamine-regulated transcript (CART), agouti-related protein (AgRP), cholecystokinin (CCK) and peptide YY (PYY) and their relationship with eating behaviors among children with attention deficit hyperactivity disorder (ADHD) and healthy controls. A total of 94 medication-free children with ADHD and 82 controls aged 8–14 years were included in this study. The Plasma levels of CART, AgRP, CCK and PYY were measured using enzyme-linked immunosorbent assay kits. The Children's Eating Behavior Questionnaire (CEBQ) was used to assess eating behaviors in children. CART and AgRP levels were found to be significantly lower in the ADHD group than in the control group, while CCK levels were found to be significantly higher in the ADHD group than in the control group. However, there was no significant difference in PYY levels between the groups. Compared to controls, those with ADHD demonstrated significantly higher scores on the CEBQ subscales of food responsiveness, emotional overeating, desire to drink, enjoyment of food, and food fussiness, and significantly lower scores on the slowness of eating subscale. CART was significantly correlated with emotional overeating and enjoyment of food scores, while AgRP was significantly correlated with emotional undereating scores. Covariance analysis was performed by controlling potential confounders such as body mass index, age and sex, and the results were found to be unchanged. It was concluded that CART, AgRP, and CCK may play a potential role in the pathogenesis of ADHD.
Web of Science Eşleşmesi Bulundu
4
WoS Atıf
129
Cilt
Article
Belge Türü
Kaynak: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Anahtar Kelimeler (WoS)
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 3.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2024 yılı verileri
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Q1
SJR Quartile
1,768
SJR Skoru
157
H-Index
Kategoriler: Biological Psychiatry (Q1) · Pharmacology (Q1)
Alanlar: Neuroscience · Pharmacology, Toxicology and Pharmaceutics
Ülke: United States
· Elsevier Inc.
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
WoS |
Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.
Makale Bilgileri
Dergi
Progress in Neuro-Psychopharmacology & Biological Psychiatry
ISSN
0278-5846
Yıl
2024
/ 2. ay
Cilt / Sayı
129
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
JCR Quartile
Q1
Yayın Dili
İngilizce
Kapsam
Uluslararası
Toplam Yazar
7 kişi
Erişim Türü
Elektronik
Alan
Sağlık Bilimleri Temel Alanı
Çocuk Sağlığı ve Hastalıkları (Çocuk Sağlığı ve Hastalıkları)
YÖKSİS Yazar Kaydı
Yazar Adı
TEZCAN MUSTAFA ESAD, UĞUR CÜNEYT, CAN ÜMMÜGÜLSÜM, UÇAK EKREM FURKAN, EKİCİ FATİH, DUYMUŞ FAHRETTİN, KORUCU AĞAH TUĞRUL
YÖKSİS ID
7501663